Skip to content

Public FDA record

Z-0665-2025: MICRO-X Rover Mobile X-ray System, # MXU-RV35; MICRO-X Rover Mobile X-ray System, # MXU-RV71

Recall record Z-0665-2025 for Micro-X Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0665-2025
Company in FDA record
Micro-X Ltd.
FDA classification date
Dec 12, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Mobile x-ray system can report and deliver a lower post-exposure mAs value than what set by the operator.

Source facts

Action
On 11/28/23 Modification 17 was sent to customers telling them that Control Boards need to be replaced with Control Board PCBA, 12425-04 that will eliminate the issue. For technical assistance contact: support-us@micro-x.com, 1-206-249-8764 Firm asked distributors to do the following: On next visit please confirm that the bulletins were completed and return the documentation.
Initiated
2023-11-28
Root cause
Device Design
Distribution
US Nationwide Distribution: NJ, CA, PR
Recall number
Z-0665-2025
Recall status
Open, Classified
CDRH record ID
210774
FDA classified
2024-12-12
Recall event number
95617

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗